scieee Science in your language
[en] (orig)

Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer

Abstract

Background and objectives: Chemotherapy does not only affect cancer cells; it also affects, to a greater or lesser degree, all other cells in the body. This toxicity should be assessed according to its severity, frequency, and duration, taking into account objective and subjective dimensions in its assessment. This assessment is a highly relevant aspect when providing care to chemotherapy patients, mainly due to the impact of the treatment on the patient's quality of life, as well as the vital risk it may imply under certain circumstances. For all this, the objective of this study was to assess the relationship between chemotherapy-associated adverse reactions and health-related quality of life in breast cancer patients. Materials and methods: With this purpose, a descriptive cross-sectional study was developed on 110 breast cancer patients who were treated with docetaxel, epirubicin, and cyclophosphamide. Results: It is worth highlighting the negative effect of nausea, dysgeusia, peripheral neuropathy, loss of appetite, myalgia, and peripheral edema on the quality of life. Likewise, it is worth mentioning peripheral neuropathy as the toxicity that affects a greater number of quality-of-life indicators. Conclusions: To sum up, it would be necessary to make health professionals aware of the importance of chemotherapy-associated adverse reactions.

Read accessible full text

Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer

Author: Prieto Callejero, Blanca; Rivera de los Santos, Francisco José; Fagundo Rivera, Javier; Romero, Adolfo; Romero Martín, Macarena; Gómez Salgado, Juan; Ruiz Frutos, Carlos
Publisher: Wolters Kluwer Health
Year: 2020
DOI: 10.1097/MD.0000000000021695
Source: https://idus.us.es/bitstreams/3f178a38-fd0a-4331-9734-b5d8544de023/download
Rela ionship be ween chemo he apy-induced
ad e se eac ions and heal h- ela ed quali y o li e
in pa ien s wi h b eas cance
Blanca P ie o-Calleje o, PhD
a
, F ancisco Ri e a, PhD
b
, Ja ie Fagundo-Ri e a, MSc, MRes
c
,
Adol o Rome o, PhD
d
, Maca ena Rome o-Ma ín, PhD
e
, Juan Gómez-Salgado, PhD
,g,∗
,
Ca los Ruiz-F u os, PhD
,g
Abs ac
Backg ound and objec i es: Chemo he apy does no only a ec cance cells; i also a ec s, o a g ea e o lesse deg ee, all
o he cells in he body. This oxici y should be assessed acco ding o i s se e i y, equency, and du a ion, aking in o accoun
objec i e and subjec i e dimensions in i s assessmen . This assessmen is a highly ele an aspec when p o iding ca e o
chemo he apy pa ien s, mainly due o he impac o he ea men on he pa ien ’s quali y o li e, as well as he i al isk i may imply
unde ce ain ci cums ances. Fo all his, he objec i e o his s udy was o assess he ela ionship be ween chemo he apy-
associa ed ad e se eac ions and heal h- ela ed quali y o li e in b eas cance pa ien s.
Ma e ials and me hods: Wi h his pu pose, a desc ip i e c oss-sec ional s udy was de eloped on 110 b eas cance pa ien s
who we e ea ed wi h doce axel, epi ubicin, and cyclophosphamide.
Resul s: I is wo h highligh ing he nega i e e ec o nausea, dysgeusia, pe iphe al neu opa hy, loss o appe i e, myalgia, and
pe iphe al edema on he quali y o li e. Likewise, i is wo h men ioning pe iphe al neu opa hy as he oxici y ha a ec s a g ea e
numbe o quali y-o -li e indica o s.
Conclusions: To sum up, i would be necessa y o make heal h p o essionals awa e o he impo ance o chemo he apy-
associa ed ad e se eac ions.
Abb e ia ions: QT =chemo he apy, TEC = ea men scheme consis ing o doce axel, epi ubicin and cyclophosphamide.
Keywo ds: b eas cance , d ug- ela ed side e ec s and ad e se eac ions, heal h- ela ed quali y o li e, pa ien sa e y, quali y o
heal h ca e, oxici ies
1. In oduc ion
Chemo he apy (QT) does no only a ec cance cells; i also
a ec s, o a g ea e o lesse deg ee, all o he cells in he body.
Specifically, he mos a ec ed cells by he cy o oxic e ec o
chemo he apy a e hose ha sha e cha ac e is ics wi h umo
cells, especially high-speed cell di ision, such as hai ollicles,
bone ma ow, diges i e ac cells, and ep oduc i e sys em cells.
The e o e, chemo he apeu ic ea men s ha e a se ies o mo e o
less se ious e ec s on he es o he body: These a e called side
e ec s o ad e se eac ions.
[1]
The Wo ld Heal h O ganiza ion defines an Ad e se D ug
Reac ion as a esponse o a medicine which is noxious and
unin ended, and which occu s a doses no mally used in man
o p ophylaxis, diagnosis, o he apy o disease o o he
modifica ion o physiologic unc ion.
This oxici y should be assessed acco ding o i s se e i y,
equency, and du a ion, aking in o accoun objec i e and
subjec i e dimensions in i s assessmen . The o me include hose
ha can be e alua ed by physical examina ion o labo a o y es s,
while he la e would include hose ha cause symp oms ha a e
no ela ed o e aluable physical signs o analy ical al e a ions,
and hey mus be assessed exclusi ely a he medical consul a ion.
The eason o assessing chemo he apy-associa ed oxici y is
because many o he ad e se eac ions could be a oided o
minimized by pe o ming a ho ough e alua ion a e each
chemo he apy cycle.
[2,3]
The possibili y o a oiding o minimizing
Edi o : Vic o C. Kok.
The au ho s ha e no conflic s o in e es o disclose.
All da a gene a ed o analyzed du ing his s udy a e included in his published
a icle [and i s supplemen a y in o ma ion files].
a
Hospi al Vi gen de la Bella, Lepe, Huel a,
b
Depa men o Expe imen al
Psychology, Facul y o Psychology, Uni e si y o Se ille, Se ille,
c
Depa men o
Heal h and Eme gencies, Spanish Red C oss, Local Commi ee o Se ille,
Doc o al P og amme, Uni e si y o Huel a, Huel a,
d
Uni e si y Hospi al Vi gen de
la Vic o ia, Nu sing and Podia y Depa men , Heal h Sciences School, Uni e si y
o Málaga, Málaga,
e
Nu sing Depa men , Facul y o Nu sing, Uni e si y o
Huel a,
P e en i e Medicine and Public Heal h Uni , Sociology, Social Wo k and
Public Heal h Depa men , Labou Sciences Facul y, Uni e si y o Huel a, Huel a,
Spain,
g
Sa e y and Heal h Pos g adua e P og amme, Uni e sidad Espí i u San o,
Guayaquil, Ecuado .
∗
Co espondence: Juan Gómez-Salgado, Depa men o Sociology, Social Wo k
and Public Heal h, Uni e si y o Huel a. A enida T es de Ma zo, s/n, Huel a
21007, Spain (e-mail: [email p o ec ed]).
Copy igh ©2020 he Au ho (s). Published by Wol e s Kluwe Heal h, Inc.
This is an open access a icle dis ibu ed unde he e ms o he C ea i e
Commons A ibu ion-Non Comme cial License 4.0 (CCBY-NC), whe e i is
pe missible o download, sha e, emix, ans o m, and buildup he wo k p o ided
i is p ope ly ci ed. The wo k canno be used comme cially wi hou pe mission
om he jou nal.
How o ci e his a icle: P ie o-Calleje o B, Ri e a F, Fagundo-Ri e a J, Rome o
A, Rome o-Ma ín M, Gómez-Salgado J, Ruiz-F u os C. Rela ionship be ween
chemo he apy-induced ad e se eac ions and heal h- ela ed quali y o li e in
pa ien s wi h b eas cance . Medicine 2020;99:33(e21695).
Recei ed: 11 Ma ch 2020 / Recei ed in final o m: 30 June 2020 / Accep ed: 6
July 2020
h p://dx.doi.o g/10.1097/MD.0000000000021695
Obse a ional S udy Medicine®
OPEN
1
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023
chemo he apy-associa ed oxici y is a highly ele an aspec in
cance pa ien ca e, mainly because o he impac i poses on he
pa ien ’s quali y o li e, as well as he i al isk i can cause unde
some ci cums ances.
[3–6]
Oncologis s gene ally main ain, educe, o delay adminis a-
ion o he nex chemo he apy cycle based on he collec ed
oxici y.
[2]
Unde es ima ion o ad e se eac ions can lead o lack
o dose adjus men s whe e app op ia e and, subsequen ly, he
unadjus ed dose may ep oduce o inc ease he complica ions
expe ienced in he p e ious cycle, leading o inc eased
mo bidi y, a oidable hospi alisa ions, o p ema u e emo al o
chemo he apy.
[3,4,7,8]
In addi ion, pa ien s unde es ima e ad e se eac ions by
conside ing hem as pa o he ea men , and e en as a sign
ha he ea men is “wo king.”
[9–11]
The e o e, as Salsman
e al
[9]
demons a e in a desc ip i e compa a i e s udy, al hough
pa ien s pe cei e hese ad e se eac ions as disabling, hey o en
unde s and hem as a no mal pa o he ea men . Fu he mo e,
pa ien s ha e o wai un il hei nex appoin men o epo any
oxici y episodes, so incidence and in ensi y a e likely o be
subjec ed o memo y biases.
On he con a y, physicians s ongly suppo he need o ea
hese oxici ies and he ele ance o p o essional abili y o he
same pu pose.
[9]
The esul ing unde - egis a ion o equency
and in ensi y con adic s doc o s’belie ha i oxici ies a e a
p oblem, hei pa ien s will in o m hem. In gene al, oncology
heal h wo ke s o en unde es ima e he incidence o chemo-
he apy-associa ed oxici ies.
[3,11,12]
By con as , he holis ic
applica ion o day hospi al nu sing ca e implies a g ea e
knowledge o hese ad e se eac ions.
[13]
Howe e , ad e se eac ions main ained du ing chemo he apy
cycles can imply a majo impac on he quali y o li e o he cance
pa ien by al e ing me abolic balance, dec easing men al
pe o mance, degene a ing sel -ca e and unc ional capaci y,
and e en inc easing he isk o wi hd awal o he chemo he apy
ea men .
[3,10,14,15]
In con as , he e a e ew s udies
[16]
ha link chemo he apy-
associa ed oxici ies wi h he pa ien s’quali y o li e. Mos o
hem a e ela ed o nausea and omi ing, lymphedema, pain, and
symp oms o p ema u e menopause.
[16,17]
Howe e , hey ba ely
collec o he oxici ies, no leas impo an o he pa ien , such as
pe iphe al neu opa hy.
[18]
Fo example, he ea men scheme consis ing o doce axel,
epi ubicin, and cyclophosphamide (TEC) has a o able clinical
ou comes o b eas cance pa ien s.
[19–24]
In con as , his
scheme is highly oxic o he pa ien ’s body, and i is necessa y o
moni o he oxici ies ha occu a e he chemo he apy
cycles.
[25,26]
This con ol would be aimed a educing he dose
a he op imal ime o a oid o e dosing.
Thus, i is impo an o know, collec , and p o ocolize clinical
pe o mance in each o he side e ec s associa ed wi h each ype
o chemo he apy d ug.
The e o e, he objec i e o his s udy was o analyze he
ela ionship be ween chemo he apy-associa ed ad e se eac ions
and he heal h- ela ed quali y o li e o b eas cance pa ien s.
2. Me hods
2.1. Design
Desc ip i e c oss-sec ional s udy. B eas cance pa ien s in
ea men wi h fi s -line neoadju an o adju an chemo he apy
wi h doce axel, epi ubicin and cyclophosphamide we e s udied.
The o al s udy pe iod was be ween May 2012 and Augus 2014,
in a second-le el hospi al (medium le el o complexi y).
2.2. Pa icipan s
The inclusion c i e ia implied all b eas cance pa ien s unde
chemo he apeu ic ea men , being i neoadju an o adju an ,
wi h he TEC egimen+filg as im o pegfilg as im colony
s imula ing ac o + iple an ieme ic he apy wi h dexame ha-
sone, ap epi an , and ondanse on, and who had a leas
unde gone 1 cycle h ough his scheme. All pa ien s who,
mee ing he inclusion c i e ia, had p e iously esponded o he
ques ionnai e de eloped in he s udy, as well as all pa ien s who
we e s a ing hei fi s ea men cycle, we e excluded.
Fo he calcula ion o he equi ed sample size, he o al
numbe o pa ien s wi h hese cha ac e is ics ini ia ing hei
ea men o 1 yea h ough he TEC scheme (app oxima ely 60)
was aken in o accoun , wi h a ep esen a i e sample size o
52 es ima ed pa ien s, a 95% confidence le el, and a maximum
es ima e e o o 5%. Howe e , i was calcula ed ha o es ima e
he di e ences in quali y o li e wi h, a leas , an a e age e ec
size (Cohen d g ea e han o equal o 0.3), based on a 95%
confidence le el, a s a is ical powe o 10%, and an accu acy o
5 poin s, a leas 78 subjec s we e equi ed. Finally, aking in o
accoun a low p opo ion o losses in esponses ( ui o a
p e iously conduc ed pilo s udy), a minimum sample size o
80 pa ien s was es ablished. The ques ionnai e was gi en
andomly, acco ding o a clus e scheme, in 1 o he 6 ea men
cycles so, when homogeneously s a ified by he apy cycles, a
minimum sample o 10/11 subjec s in each o he cycles was
es ima ed.
The final sample consis ed o 112 women wi h b eas cance
who me he es ablished inclusion c i e ia, hus exceeding he
minimum es ablished sample and collec ing, in mos cycles, mo e
han he 10/11 p e iously es ablished pa ien s. All he pa ic-
ipan s comple ed he 6 chemo he apy cycles. Two pa ien s
e en ually declined o pa icipa e in he s udy, so hei da a we e
omi ed, and his esul ed in a final sample o 110 pa ien s.
2.3. Ins umen s
An “ad hoc”ques ionnai e was p epa ed o he pa ien ,
including all common nonhema ological ad e se eac ions
obse ed wi h he TEC scheme in p e ious clinical ials,
[24,27]
as well as he specifica ion shee o each d ug, collec ed in he
Spanish Agency o Medicines and Medical P oduc s. These
oxici ies we e subsequen ly deli e ed, o ex e nal alida ion
using a Delphi echnique, o 11 oncologis s ela ed o b eas
cance o speci y he es ima ed equency o each oxici y. In
addi ion, hey we e asked whe he hey conside ed ha he e was
any o he ad e se eac ion o be aken in o accoun . The esul
was posi i e o he p epa ed ques ionnai e.
To ob ain he e ifica ion o alidi y, he ques ionnai e was
subjec ed o p e ious s udy. To his end, he ques ionnai e was
p o ided o an ini ial sample o 12 b eas cance pa ien s
unde going he TEC scheme and o 5 oncologis s who ea ed
b eas cance o assess, on he one hand, he unde s anding o he
ques ionnai e and, on he o he hand, he comple eness in he
collec ion o he mos common ad e se symp oma ology in his
ype o ea men . The esul s showed he adequacy o he
ques ionnai e o he p oposed pu poses.
P ie o-Calleje o e al. Medicine (2020) 99:33 Medicine
2
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023
Fo he assessmen o heal h- ela ed quali y o li e, he
Eu oQol-5D ques ionnai e
[28]
was used o p esen ing an A
le el o ecommenda ion and because i bes sui ed he needs o
he s udy. Se e al s udies suppo ed he alidi y o he EQ-5D-3L
index.
[29–31]
2.4. P ocedu e
Medical p esc ip ions ha e been e iewed daily by loca ing he
pa ien s unde s udy. These pa ien s had o p e-en e he
oncology consul a ion and hen go o he Day Hospi al o
ecei e hei ea men . A day hospi al is a heal h-cen e ed
s uc u e h ough which he pa ien is admi ed o a planned
numbe o hou s du ing which hey ecei e specialized ea men
om he specialis s. These ea men s equi e moni o ing o
medical equipmen ha mus be handled wi hin he medical
p emises. A he end o he ca e, he pa ien e u ns home. Then,
a he Day Hospi al, each pa ien was gi en he ques ionnai e,
ha is, he subjec o s udy, wi h which she esponded o he
oxici ies su e ed in he p e ious 21 days, ha is, in he p e ious
cycle. The ques ionnai e was gi en andomly in 1 o he 6
ea men cycles. The objec i e and how o app op ia ely answe
he ques ions we e explained in de ail. Once comple ed, he
pa ien was excluded o he ollowing cycles. In addi ion, he
help o nu ses was a ailable a all imes o help wi h any doub s
when filling he ques ionnai e. All he pa ien s signed he
in o med consen a e ecei ing in o ma ion on i and all he
possible doub s had been esol ed by he main esea che .
2.5. Da a analysis
Desc ip i e s a is ics, con as es s o p opo ions (x
2
es ) and
means (S uden es and Mann–Whi ney U es ), ag eemen le el
con as (Cohen Kappa), and e ec size assessmen echniques
(Phi, C ame V, and Cohen d) we e used. The s a is ical so wa e
used was IBM SPSS S a is ics 22.0 and EQS 6.2. In all cases, a
s a is ical significance o P<.05 was equi ed.
2.6. E hical aspec s
The s udy was ca ied ou , o he de elopmen and ollow-up o
he clinical esea ch, ollowing he “E hical P inciples o Medical
Resea ch wi h Humans”compiled in he la es e sion o he
Helsinki Decla a ion (Edinbu gh e sion, Oc obe 2000). This
s udy was app o ed by he Resea ch E hics Commi ee o he
p o ince o Huel a on May 2013, wi h esea ch code: PRI-TEC-
2012-01. In all cases, he anonymi y o he pa icipan s was
gua an eed. In addi ion, an in o med w i en consen was
ob ained p io o pa icipa ion, and he esea ch p o ocol
included he app o al o he Huel a Biomedical Resea ch E hics
Commi ee. In addi ion, he basic Law 41/2002 egula ing pa ien
au onomy and igh s and obliga ions in he field o in o ma ion
and clinical documen a ion was implemen ed.
3. Resul s
The final sample consis ed o 110 women. The p ofile o he s udy
pa icipan is a woman wi h an a e age age o 49.61 ( ypical
de ia ion o 8.28 yea s and wi h a ange o age om 29 o 68
yea s), ma ied (78.9%), wi h child en (83.5%), who is usually
accompanied du ing he consul a ion (96.2%). All he pa ien s
comple ed he 6 chemo he apy cycles.
The ype o ecei ed ea men was ela i ely homogeneous
be ween neoadju an (p esu ge y) and adju an (pos su ge y)
ea men , wi h esul s o abou 50%. Specifically, he pe cen age
o pa ien s who we e ecei ing he ea men as a neoadju an
was 44.5%, and 55.5% as adju an . The majo i y o pa ien s
esponded o he ques ionnai e o include he ad e se eac ions
su e ed a e he 21 days ha las ed hei fi s (26.4%) and
second (26.4%) cycle o chemo he apy. The cycle wi h he lowes
esponse a e was he fi h one (8.2%), his being he las da a
collec ion cycle (Table 1).
On he o he hand, 52.3% o pa ien s main ained he same
dose as he one p esc ibed a he beginning o he fi s
chemo he apy cycle. Howe e , in 47.7% o pa ien s, his dose
had o be educed in 20% due o hema ological oxici y
(neu openia) o nonhema ological oxici y (pe iphe al neu opa-
hy, dia hoea, e c). Specifically, 62.5% o pa ien s s a ed hei
second chemo he apy cycle wi h a educed dose.
Likewise, 66.4% o pa ien s did no a end an eme gency
depa men du ing he whole p ocess. Howe e , 33.6% o hose
a ending he eme gency depa men we e e en ually admi ed o
hospi al o an a e age o 3 days. 56.7% we e admi ed due o
oxici ies su e ed du ing he fi s chemo he apy cycle.
As o he ela ionship be ween he quali y o li e and he
specific chemo he apy cycle, no significan di e ence was ound
(P=.154). Howe e , by analyzing he e ec size, a g ea end is
obse ed be ween he quali y o li e in he fi s cycle and he
second cycle (Cohen d=0.81). In pa icula , he e is a highe
quali y o li e du ing he fi s cycle (mean=15.16) han du ing he
second cycle (mean=13.81). In all o he cycles, he e ec size is
no significan .
Likewise, looking a he di e en indica o s o quali y o li e on
he gene al popula ion o he s udy, i is obse ed ha mos
pa ien s conside ha hey ha e no p oblems wi h walking
(73.4%), sel -ca e (95.4%), e e yday ac i i ies (53.2%) and, in
addi ion, hey a e no anxious o dep essed (63.9%). In con as ,
56.9% o pa ien s eel mode a e pain o discom o , and 67.9%
pe cei e hei o e all heal h wo se han hey did a yea ago.
On he o he hand, i is impo an o no e ha 3 pa ien s had o
be in bed and 1 pa ien was unable o pe o m daily ac i i ies. In
addi ion, 4 pa ien s el a lo o pain o discom o in ha cycle,
and 5 pa ien s el e y anxious o dep essed.
3.1. Gas oin es inal oxici y
S a is ically significan di e ences ha e been es ablished o he
ela ionship nausea-quali y o li e [U (77)=440, P=.020], wi h
Table 1
Desc ip ion o he sample in e ms o ea men cha ac e is ics.
Numbe o pa ien s % o pa ien s
Cycle Fi s cycle 29 26.4%
Second cycle 29 26.4%
Thi d cycle 19 17.3%
Fo h cycle 24 21.8%
Fi h cycle 9 8.2%
Adju ancy Neoadju ancy 49 44.5%
Adju ancy 61 55.5%
Dose eadjus men No 59 52.3%
Yes 51 47.7%
Hospi alisa ion No 74 66.4%
Yes 36 33.6%
P ie o-Calleje o e al. Medicine (2020) 99:33 www.md-jou nal.com
3
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023
an a e age e ec size (Cohen d=0.56). In pa icula , wo se
quali y-o -li e indica o s a e obse ed in hose pa ien s who
epo ha ing su e ed nausea (mean=13.88), as compa ed wi h
hose who do no ha e his symp om (mean=14.88). In addi ion,
when analyzing each o he quali y-o -li e componen s, i is
obse ed ha pa ien s wi h nausea ha e wo se anxie y o
dep ession indica o s [x
2
(2)=7.600, P=.022, C ame V=
0.267]. In pa icula , 54.9% o pa ien s wi h nausea showed no
anxie y o dep ession indica o s, as compa ed wi h 80.6% o
pa ien s who did no p esen his oxici y (Table 2).
As o omi ing, dia hea, cons ipa ion, and mucosi is, no
s a is ically significan di e ences ha e been ound in ela ion o
he quali y o li e, and he e ec size has been negligible, excep
o mucosi is, whe e he e is a small size e ec (Cohen d=0.46). I
has no been possible o es ablish i s influence on each o he
quali y-o -li e componen s.
Table 2
Dis ibu ion o he di e en indica o s o heal h- ela ed quali y o li e based on gas oin es inal oxici y indica o s.
Vomi ing Nausea Dia hoea Cons ipa ion
No Yes No Yes No Yes No Yes
Mobili y I ha e no p oblems walking 73.2% (71) 72.7% (8) 77.8% (28) 70.8% (51) 76.8% (43) 69.8% (37) 71.6% (48) 75.0% (30)
I ha e some p oblems walking 23.7% (23) 27.3% (3) 22.2% (8) 25.0% (18) 21.4% (12) 26.4% (14) 25.4% (17) 22.5% (9)
I ha e o s ay in bed 3.1% (3) 0.0% (0) 0.0% (0) 4.2% (3) 1.8% (1) 3.8% (2) 3.0% (2) 2.5% (1)
Pe sonal ca e I ha e no p oblems wi h pe sonal
ca e
95.9% (93) 90,0% (9) 97.2% (35) 94.4% (67) 92.9% (52) 98.1% (51) 93.9% (62) 97.5% (39)
I ha e some p oblems washing
mysel and ge ing d essed
4.1% (4) 10,0% (1) 2.8% (1) 5.6% (4) 7.1% (4) 1.9% (1) 6.1% (4) 2.5% (1)
I canno wash mysel o ge
d essed
0.0% (0) 0,0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Daily ac i i ies I ha e no p oblems pe o ming
my daily ac i i ies
53.6% (52) 45,5% (5) 55.6% (20) 51.4% (37) 58.9% (33) 47.2% (25) 50.7% (34) 55.0% (22)
I ha e some p oblems
pe o ming my daily ac i i ies
45.4% (44) 54,5% (6) 44.4% (16) 47.2% (34) 41.1% (23) 50.9% (27) 47.8% (32) 45.0% (18)
I canno pe o m my daily
ac i i ies
1.0% (1) 0,0% (0) 0.0% (0) 1.4% (1) 0.0% (0) 1.9% (1) 1.5% (1) 0.0% (0)
Pain/discom o I ha e no pain o discom o 42.3% (41) 18,2% (2) 52.8% (19) 33.3% (24) 48.2% (27) 30.2% (16) 38.8% (26) 42.5% (17)
I ha e mode a e pain o
discom o
54.6% (53) 72,7% (8) 47.2% (17) 61.1% (44) 50.0% (28) 64.2% (34) 56.7% (38) 55.0% (22)
I ha e a lo o pain o discom o 3.1% (3) 9,1% (1) 0.0% (0) 5.6% (4) 1.8% (1) 5.7% (3) 4.5% (3) 2.5% (1)
Anxie y/dep ession I am no anxious o dep essed 61.9% (60) 80,0% (8) 80.6% (29) 54.9% (39) 69.6% (39) 57.7% (30) 66.7% (44) 57.5% (23)
I am mode a ely anxious o
dep essed
34.0% (33) 10,0% (1) 19.4% (7) 38.0% (27) 26.8% (15) 36.5% (19) 30.3% (20) 35.0% (14)
I am e y anxious o dep essed 4.1% (4) 10,0% (1) 0.0% (0) 7.0% (5) 3.6% (2) 5.8% (3) 3.0% (2) 7.5% (3)
Heal h s a us Be e 10.1% (7) 0,0% (0) 8.0% (2) 9.6% (5) 8.3% (3) 9.5% (4) 6.3% (3) 14.3% (4)
Same 23.2% (16) 25,0% (2) 36.0% (9) 17.3% (9) 13.9% (5) 31.0% (13) 20.8% (10) 28.6% (8)
Wo se 66.7% (46) 75,0% (6) 56.0% (14) 73.1% (38) 77.8% (28) 59.5% (25) 72.9% (35) 57.1% (16)
Mucosi is Dysgeusia Loss o appe i e
No Yes No Yes No Yes
I ha e no p oblems walking 75.8% (47) 69.6% (32) 92.3% (12) 70.8% (68) 80.0% (44) 66.7% (36)
Mobili y I ha e some p oblems walking 22.6% (14) 26.1% (12) 7.7% (1) 26.0% (25) 18.2% (10) 29.6% (16)
I ha e o s ay in bed 1.6% (1) 4.3% (2) 0.0% (0) 3.1% (3) 1.8% (1) 3.7% (2)
I ha e no p oblems wi h pe sonal ca e 96.8% (60) 93.3% (42) 92.3% (12) 95.8% (91) 96.4% (53) 94.3% (50)
Pe sonal ca e I ha e some p oblems washing mysel
and ge ing d essed
3.2% (2) 6.7% (3) 7.7% (1) 4.2% (4) 3.6% (2) 5.7% (3)
I canno wash mysel o ge d essed 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
I ha e no p oblems pe o ming my daily
ac i i ies
54.8% (34) 50.0% (23) 76.9% (10) 50.0% (48) 65.5% (36) 40.7% (22)
Daily ac i i ies I ha e some p oblems pe o ming my
daily ac i i ies
43.5% (27) 50.0% (23) 23.1% (3) 49.0% (47) 34.5% (19) 57.4% (31)
I canno pe o m my daily ac i i ies 1.6% (1) 0.0% (0) 0.0% (0) 1.0% (1) 0.0% (0) 1.9% (1)
I ha e no pain o discom o 46.8% (29) 30.4% (14) 84.6% (11) 33.3% (32) 49.1% (27) 29.6% (16)
Pain/discom o I ha e mode a e pain o discom o 51.6% (32) 63.0% (29) 15.4% (2) 62.5% (60) 50.9% (28) 63.0% (34)
I ha e a lo o pain o discom o 1.6% (1) 6.5% (3) 0.0% (0) 4.2% (4) 0.0% (0) 7.4% (4)
I am no anxious o dep essed 66.1% (41) 60.0% (27) 84.6% (11) 61.1% (58) 70.9% (39) 56.6% (30)
Anxie y / dep ession I am mode a ely anxious o dep essed 33.9% (21) 28.9% (13) 15.4% (2) 33.7% (32) 27.3% (15) 35.8% (19)
I am e y anxious o dep essed 0.0% (0) 11.1% (5) 0.0% (0) 5.3% (5) 1.8% (1) 7.5% (4)
Be e 10.9% (5) 6.5% (2) 16.7% (1) 8.3% (6) 10.3% (4) 7.7% (3)
Heal h s a us Same 23.9% (11) 22.6% (7) 50.0% (3) 20.8% (15) 35.9% (14) 10.3% (4)
Wo se 65.2% (30) 71.0% (22) 33.3% (2) 70.8% (51) 53.8% (21) 82.1% (32)
In pa en heses: numbe o pa ien s.
P ie o-Calleje o e al. Medicine (2020) 99:33 Medicine
4
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023
In e ms o loss o appe i e, s a is ically significan di e ences
ha e been ound [U (78)=455, P=.002], wi h an a e age e ec
size (Cohen d=0.77). In pa icula , wo se quali y-o -li e
indica o s a e obse ed in pa ien s who epo loss o appe i e
(mean=13.56), as compa ed wi h hose who do no show his
p oblem (mean=14.87).
Based on he influence on each o he quali y-o -li e
componen s, i is obse ed ha pa ien s wi h loss o appe i e
ha e wo se indica o s ega ding daily ac i i ies [x
2
(2)=7.251,
P=.027, C ame V=0.258], pain o discom o [x
2
(2)=7.386,
P=025, C ame V=0.260], and gene al heal h s a us [x
2
(2)=
7.981, P=.018, C ame V=0.320].
Finally, dysgeusia show s a is ically significan di e ences [U
(78)=107, P=.038] and a la ge e ec size (Cohen d=0.89). In
pa icula , wo se quali y-o -li e ou comes a e shown in pa ien s
wi h as e impai men (mean=14.10), as compa ed wi h hose
who do no show his al e a ion (mean=15.67).
In addi ion, when analyzing each o he quali y-o -li e
componen s, i is obse ed ha pa ien s wi h dysgeusia ha e
wo se pain o discom o indica o s [x
2
(2)=12.643, P=.002,
C ame V=0.341].
3.2. De ma ological oxici y
In e ms o de ma ological oxici ies, no s a is ically significan
di e ences in skin eac ion in hands and/o ee and in impai ed
nails ha e been ound. In bo h oxici ies, he e ec size has been
negligible. Likewise, hese de ma ological oxici ies ha e no
shown any s a is ical ela ionship wi h he di e en quali y-o -li e
componen s.
In con as , ega ding skin alle gies, he e a e s a is ically
significan di e ences [U (76)=213, P=.014) and a la ge e ec
size (Cohen d=0.88). In pa icula , be e quali y-o -li e
indica o s a e shown in pa ien s wi h skin alle gies (mean=
15.50), as compa ed wi h hose who do no e e his symp om
(mean=13.95). No di e ences ha e been ound be ween each o
he quali y-o -li e componen s. Howe e , by analyzing he e ec
size, di e ences can be ound ega ding he gene al heal h s a e
[x
2
(2)=5.275, P=.072, C ame V=0.263]. In pa icula ,
66.7% o pa ien s wi h skin alle gies show a wo se gene al
heal h s a us, as compa ed wi h 67.2% o pa ien s wi hou his
oxici y (Table 3).
3.3. Neu ological oxici y
Pe iphe al neu opa hy has been con as ed wi h he quali y o
li e, finding s a is ically significan di e ences [U (77)=185,
P=.000] and also a la ge e ec size (Cohen d=1.34). In
pa icula , wo se heal h- ela ed quali y o li e indica o s a e
ound in pa ien s who claim o ha e pe iphe al neu opa hy
(mean=12.53), as compa ed wi h hose who do no (mean=
14.68).
Subsequen ly, as shown in Table 4, i is obse ed ha pa ien s
wi h pe iphe al neu opa hy ha e wo se pe sonal ca e indica o s
[x
2
(1)=4.608, P=.032, C ame V=0.208], daily ac i i ies
[x
2
(2)=9.525, P=.009, C ame V=0.297], pain o discom o
[x
2
(2)=11.725, P=0.003, C ame V=0.329], and anxie y o
dep ession [x
2
(2)=6.032, P=0.049, C ame V=0.237].
3.4. Pain- ela ed oxici y
As o headaches, abdominal pain, and join pain, no s a is ically
significan di e ences ha e been ound, and he e ec size is
small. On he o he hand, when analyzing each o he quali y-o -
li e componen s, no di e ence can be ound as ega ds he
p esence o absence o hese oxici ies.
In con as , ega ding abdominal pain, he e a e di e ences as
o pain o discom o [x
2
(2)=5.118, P=0.077, C ame V=
0.218] and gene al heal h s a us [x
2
(2)=3.206, P=.201, C ame
V=0.204). In e ms o join pain, he e a e di e ences in pain o
discom o indica o s [x
2
(2)=15.368, P=.000, C ame V=
0.377].
Table 3
Dis ibu ion o he di e en indica o s o heal h- ela ed quali y o li e based on de ma ological oxici y indica o s.
Hands/ ee skin eac ion Nail oxici y Skin alle gies
No Yes No Yes No Yes
Mobili y I ha e no p oblems walking 70.4% (57) 81.5% (22) 73.0% (54) 73.5% (25) 68.6% (59) 90.5% (19)
I ha e some p oblems walking 25.9% (21) 18.5% (5) 24.3% (18) 23.5% (8) 27.9% (24) 9.5% (2)
I ha e o s ay in bed 3.7% (3) 0,0% (0) 2.7% (2) 2.9% (1) 3.5% (3) 0.0% (0)
Pe sonal ca e I ha e no p oblems wi h pe sonal ca e 95.1% (77) 96.2% (25) 95.9% (70) 94.1% (32) 94.2% (81) 100.0% (20)
I ha e some p oblems washing mysel
and ge ing d essed
4.9% (4) 3.8% (1) 4.1% (3) 5.9% (2) 5.8% (5) 0.0% (0)
I canno wash mysel o ge d essed 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Daily ac i i ies I ha e no p oblems pe o ming my daily ac i i ies 50.6% (41) 59.3% (16) 59.5% (44) 41.2% (14) 51.2% (44) 61.9% (13)
I ha e some p oblems pe o ming my daily ac i i ies 49.4% (40) 37.0% (10) 39.2% (29) 58.8% (20) 47.7% (41) 38.1% (8)
I canno pe o m my daily ac i i ies 0.0% (0) 3.7% (1) 1.4% (1) 0.0% (0) 1.2% (1) 0.0% (0)
Pain/discom o I ha e no pain o discom o 42.0% (34) 29.6% (8) 44.6% (33) 29.4% (10) 37.2% (32) 47.6% (10)
I ha e mode a e pain o discom o 55.6% (45) 63.0% (17) 51.4% (38) 67.6% (23) 58.1% (50) 52.4% (11)
I ha e a lo o pain o discom o 2.5% (2) 7.4% (2) 4.1% (3) 2.9% (1) 4.7% (4) 0.0% (0)
Anxie y / dep ession I am no anxious o dep essed 63.0% (51) 65.4% (17) 65.8% (48) 61.8% (21) 59.3% (51) 80.0% (16)
I am mode a ely anxious o dep essed 33.3% (27) 26.9% (7) 28.8% (21) 35.3% (12) 34.9% (30) 20.0% (4)
I am e y anxious o dep essed 3.7% (3) 7.7% (2) 5.5% (4) 2.9% (1) 5.8% (5) 0.0% (0)
Heal h s a us Be e 8.6% (5) 10.5% (2) 12.7% (7) 0.0% (0) 6.3% (4) 25.0% (3)
Same 24.1% (14) 21.1% (4) 21.8% (12) 27.3% (6) 26.6% (17) 8.3% (1)
Wo se 67.2% (39) 68.4% (13) 65.5% (36) 72.7% (16) 67.2% (43) 66.7% (8)
In pa en heses: numbe o pa ien s.
P ie o-Calleje o e al. Medicine (2020) 99:33 www.md-jou nal.com
5
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023

As o muscle pain, s a is ically significan di e ences ha e
been ound [U (77)=436, P=.003], and he e ec size is
mode a e (Cohen d=0.76). In pa icula , wo se quali y-o -li e
indica o s a e ound in hose pa ien s wi h myalgia (mean=13.6,
9), as compa ed wi h hose who do no show his symp om
(mean=15.00). Then, when analyzing each o he quali y-o -li e
componen s, i is obse ed ha pa ien s wi h myalgia ha e wo se
pain o discom o [x
2
(2)=16.166, P=.000, C ame V=0.387]
and gene al heal h s a us indica o s [x
2
(2)=7.831, P=.020,
C ame V=0.319) (Table 5).
3.5. Eye oxici y
Rega ding conjunc i i is, no s a is ically significan di e ences
ha e been ound, bu an app op ia e, al hough small, e ec size is
shown (Cohen d=0.35). Rega ding his oxici y, wo se quali y-
o -li e indica o s a e obse ed in pa ien s wi h he conjunc i i is
(mean=13.83), as compa ed wi h hose who do no show his
symp om (mean=14.46).
By analyzing each o he quali y-o -li e componen s, no
s a is ically significan di e ence has been ound be ween hem.
Howe e , by analyzing he e ec size, di e ences in he gene al
heal h s a us a e ound [x
2
(2)=3.337, P=.189, C ame V=
0.207]. In pa icula , 80.0% o pa ien s wi h conjunc i i is a e
hei gene al heal h s a us as wo se, as compa ed wi h 60.4% o
pa ien s who do no ha e his eye oxici y (Table 6).
3.6. Cons i u ional symp oms
The p esence o as henia has hen been con as ed wi h he
quali y o li e, whe e no s a is ically significan di e ences ha e
been ound and he e ec size has been mode a e (Cohen d=
0.64). In pa icula , wo se quali y-o -li e indica o s a e ound in
hose pa ien s who e e as henia (mean=14.09), as compa ed
wi h hose who do no show his oxici y (mean=15.25).
On he o he hand, when analyzing each o he quali y-o -li e
componen s, i is obse ed ha pa ien s wi h as henia ha e wo se
mobili y [x
2
(2)=11.442, P=.003, C ame V=0.325], daily
ac i i ies [x
2
(2)=6.137, P=.046, C ame =0.238), and pain o
discom o indica o s [x
2
(2)=6.762, P=.034, C ame V=.250]
(Table 7).
3.7. Lympha ic sys em oxici y
In e ms o oxici y a ec ing he lympha ic sys em, pe iphe al
edema, s a is ically significan di e ences, and a la ge e ec size
ha e been ound (Cohen d=0.88). In pa icula , pa ien s wi h
pe iphe al edema (mean=13.20) show wo se quali y-o -li e
indica o s han hose wi hou his oxici y (mean=14.69).
Then, when analyzing each o he quali y-o -li e componen s, i
is obse ed ha pa ien s wi h pe iphe al edema ha e wo se
mobili y [x
2
(2)=19.875, P=.000, C ame V=0.429], pain o
discom o [x
2
(2)=9.875, P=.007, C ame V=0.302], and
gene al heal h s a us indica o s [x
2
(2)=7.096, P=029, C ame
V=0.304] (Table 8).
Co ela ions be ween ad e se eac ions and heal h- ela ed
quali y o li e a e summa ized in Table 9.
4. Discussion
Chemo he apy ea men s a e ela ed o majo oxici ies ha
mus be closely moni o ed by he doc o a each o he pa ien ’s
consul a ions, p io o he adminis a ion o he nex chemo-
he apy cycle, in a simila way o he collec ion o oxici ies in he
con ex o a clinical ial. Howe e , in s anda d clinical p ac ice,
he pa ien ’s assump ion ha oxici ies a e una oidable and
in insic o he ea men makes he collec ion o nonhema o-
logical ad e se eac ions incomple e.
Meanwhile, as P ies man and Baum
[28]
demons a ed in 1976,
he influence o ad e se eac ions on he quali y o li e o cance
pa ien s is highly ele an . The e a e s udies
[32]
ha show ha
low quali y o li e nega i ely p edisposes o he onse o ce ain
diseases, including b eas cance . The e o e, i can be concluded
Table 4
Dis ibu ion o he di e en indica o s o heal h- ela ed quali y o li e based on neu ological oxici y indica o s.
Pe iphe al neu opa hy
No Yes
Mobili y I ha e no p oblems walking 76.2% (64) 62.5% (15)
I ha e some p oblems walking 21.4% (18) 33.3% (8)
I ha e o s ay in bed 2.4% (2) 4.2% (1)
Pe sonal ca e I ha e no p oblems wi h pe sonal ca e 97.6% (82) 87.0% (20)
I ha e some p oblems washing mysel and ge ing d essed 2.4% (2) 13.0% (3)
I canno wash mysel o ge d essed 0.0% (0) 0.0% (0)
Daily ac i i ies I ha e no p oblems pe o ming my daily ac i i ies 59.5% (50) 29.2% (7)
I ha e some p oblems pe o ming my daily ac i i ies 40.5% (34) 66.7% (16)
I canno pe o m my daily ac i i ies 0.0% (0) 4.2% (1)
Pain/discom o I ha e no pain o discom o 46.4% (39) 16.7% (14)
I ha e mode a e pain o discom o 52.4% (44) 70.8% (17)
I ha e a lo o pain o discom o 1.2% (1) 12.5% (3)
Anxie y/dep ession I am no anxious o dep essed 67.9% (57) 47.8% (11)
I am mode a ely anxious o dep essed 29.8% (25) 39.1% (9)
I am e y anxious o dep essed 2.4% (2) 13.0% (3)
Heal h s a us Be e 10.0% (6) 5.9% (1)
Same 28.3% (17)
Wo se 61.7% (3) 88.2% (15)
In pa en heses: numbe o pa ien s.
P ie o-Calleje o e al. Medicine (2020) 99:33 Medicine
6
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023
ha a poo es quali y o li e has a nega i e impac on add essing
he ea men p ocess.
The esul s o his s udy highligh he nega i e impac o
oxici ies such as nausea, dysgeusia, pe iphe al neu opa hy, loss
o appe i e, myalgia, and pe iphe al edema on b eas cance
pa ien s’quali y o li e. As Ga cía-Luna e al
[33]
show, nausea,
dysgeusia, and loss o appe i e induce he onse o malnu i ion in
he cance pa ien . This leads o a dec ease in muscle mass and,
he e o e, a o s o e all weakness o he pa ien . I s impac
implies, in addi ion o dec easing quali y o li e (da a
Table 6
Dis ibu ion o he di e en indica o s o heal h- ela ed quali y o li e based on eye oxici y indica o s.
Conjunc i i is
No Yes
Mobili y I ha e no p oblems walking 78.8% (52) 65.1% (28)
I ha e some p oblems walking 18.2% (12) 32.6% (14)
I ha e o s ay in bed 3.0% (2) 2.3% (1)
Pe sonal ca e I ha e no p oblems wi h pe sonal ca e 95.5% (63) 95.2% (40)
I ha e some p oblems washing mysel and ge ing d essed 4.5% (3) 4.8% (2)
I canno wash mysel o ge d essed 0.0% (0) 0.0% (0)
Daily ac i i ies I ha e no p oblems pe o ming my daily ac i i ies 54.5% (36) 51.2% (22)
I ha e some p oblems pe o ming my daily ac i i ies 45.5% (30) 46.5% (20)
I canno pe o m my daily ac i i ies 0.0% (0) 2.3% (1)
Pain/discom o I ha e no pain o discom o 43.9% (29) 32.6% (14)
I ha e mode a e pain o discom o 53.0% (35) 62.8% (27)
I ha e a lo o pain o discom o 3.0% (2) 4.7% (2)
Anxie y/dep ession I am no anxious o dep essed 62.1% (41) 66.7% (28)
I am mode a ely anxious o dep essed 33.3% (22) 28.6% (12)
I am e y anxious o dep essed 4.5% (3) 4.8% (2)
Heal h s a us Be e 10.4% (5) 6.7% (2)
Same 29.2% (14) 13.3% (4)
Wo se 60.4% (29) 80.0% (24)
In pa en heses: numbe o pa ien s.
Table 5
Dis ibu ion o he di e en indica o s o heal h- ela ed quali y o li e based on pain- ela ed oxici y indica o s.
Headache Abdominal pain Join pain Muscle pain
No Yes No Yes No Yes No Yes
Mobili y I ha e no p oblems walking 68.0% (34) 77.6% (45) 72.7% (48) 73.8% (31) 80.5% (33) 68.7% (46) 80.0% (36) 69.8% (44)
I ha e some p oblems walking 30.0% (15) 19.0% (11) 24.2% (16) 23.8% (10) 17.1% (7) 28.4% (19) 17.8% (8) 27.0% (17)
I ha e o s ay in bed 2.0% (1) 3.4% (2) 3.0% (2) 2.4% (1) 2.4% (1) 3.0% (2) 2.2% (1) 3.2% (2)
Pe sonal ca e I ha e no p oblems wi h pe sonal
ca e
98.0% (49) 93.0% (53) 95.5% (63) 95.1% (39) 97.6% (40) 93.9% (62) 95.6% (43) 95.2% (59)
I ha e some p oblems washing
mysel and ge ing d essed
2.0% (1) 7.0% (4) 4.5% (3) 4.9% (2) 2.4% (1) 6.1% (4) 4.4% (2) 4.8% (3)
I canno wash mysel o ge
d essed
0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
Daily ac i i ies I ha e no p oblems pe o ming
my daily ac i i ies
50.0% (25) 55.2% (32) 59.1% (39) 42.9% (18) 58.5% (24) 49.3% (33) 64.4% (29) 46.0% (29)
I ha e some p oblems
pe o ming my daily ac i i ies
50.0% (25) 43.1% (25) 40.9% (27) 54.8% (23) 41.5% (17) 49.3% (33) 35.6% (16) 52.4% (33)
I canno pe o m my daily
ac i i ies
0.0% (0) 1.7% (1) 0.0% (0) 2.4% (1) 0.0% (0) 1.5% (1) 0.0% (0) 1.6% (1)
Pain/discom o I ha e no pain o discom o 48.0% (24) 32.8% (19) 47.0% (31) 28.6% (12) 63.4% (26) 25.4% (17) 62.2% (28) 23.8% (15)
I ha e mode a e pain o
discom o
48.0% (24) 63.8% (37) 51.5% (34) 64.3% (27) 34.1% (14) 70.1% (47) 35.6% (16) 71.4% (45)
I ha e a lo o pain o discom o 4.0% (2) 3.4% (2) 1.5% (1) 7.1% (3) 2.4% (1) 4.5% (3) 2.2% (1) 4.8% (3)
Anxie y/dep ession I am no anxious o dep essed 66.0% (33) 61.4% (35) 72.7% (48) 48.8% (20) 61.0% (25) 65.2% (43) 68.9% (31) 59.7% (37)
I am mode a ely anxious o
dep essed
30.0% (15) 33.3% (19) 22.7% (15) 46.3% (19) 36.6% (15) 28.8% (19) 26.7% (12) 35.5% (22)
I am e y anxious o dep essed 4.0% (2) 5.3% (3) 4.5% (3) 4.9% (2) 2.4% (1) 6.1% (4) 4.4% (2) 4.8% (3)
Heal h s a us Be e 10.8% (4) 7.5% (3) 8.7% (4) 9.7% (3) 12.0% (3) 7.7% (4) 18.8% (6) 2.2% (1)
Same 29.7% (11) 17.5% (7) 30.4% (14) 12.9% (4) 24.0% (6) 23.1% (12) 28.1% (9) 20.0% (9)
Wo se 59.5% (22) 75.0% (30) 60.9% (28) 77.4% (24) 64.0% (16) 69.2% (36) 53.1% (17) 77.8% (35)
In pa en heses: numbe o pa ien s.
P ie o-Calleje o e al. Medicine (2020) 99:33 www.md-jou nal.com
7
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023
co obo a ed in his s udy), an inc ease in dependence on ca e by
amily membe s o ca egi e s and an inc eased s a e o
immunosupp ession, which is associa ed wi h he isk o
in ec ious complica ions. I is easonable o conclude ha all
o his will psychologically a ec he cance pa ien .
Fu he mo e, i is no ewo hy ha 89.9% o pa ien s deny
ha ing su e ed an episode o omi ing and ha 75.2% o hem
ha e no su e ed pe iphe al edema du ing he las 21 days.
Howe e , omi ing is commonly epo ed as associa ed wi h
hese chemo he apy ea men s.
[9]
The low incidence o omi ing
e e ed o in his s udy may be due o he high e ficacy o he used
p ophylac ic an ieme ic: ap epi an .
[34,35]
Howe e , ea men
wi h ap epi an does no educe nausea, some hing ha is
confi med by 67.0% o pa ien s in his s udy who claim o ha e
su e ed i . Likewise, he p ophylac ic use o co icos e oids may
be associa ed wi h he low pe cen age o pe iphe al edema
epo ed.
In addi ion, o he oxici ies such as mucosi is, headache,
abdominal pain, a h algia, conjunc i i is, and as henia showed a
nega i e end on he pa ien s’quali y o li e, so i could be
expec ed ha , by inc easing he sample size, his end would
become clea e and s a is ically significan .
Likewise, his s udy demons a es he nega i e implica ion o
he di e en oxici ies on each o he heal h- ela ed quali y-o -li e
Table 8
Dis ibu ion o he di e en indica o s o heal h- ela ed quali y o li e based on lympha ic sys em oxici y indica o s.
Pe iphe al edema
No Yes
Mobili y I ha e no p oblems walking 82.7% (67) 44.4% (12)
I ha e some p oblems walking 13.6% (11) 55.6% (15)
I ha e o s ay in bed 3.7% (3) 0.0% (0)
Pe sonal ca e I ha e no p oblems wi h pe sonal ca e 97.5% (79) 88.5% (23)
I ha e some p oblems washing mysel and ge ing d essed 2.5% (2) 11.5% (3)
I canno wash mysel o ge d essed 0.0% (0) 0.0% (0)
Daily ac i i ies I ha e no p oblems pe o ming my daily ac i i ies 58.0% (47) 37.0% (10)
I ha e some p oblems pe o ming my daily ac i i ies 42.0% (34) 59.3% (16)
I canno pe o m my daily ac i i ies 0.0% (0) 3.7% (1)
Pain/discom o I ha e no pain o discom o 48.1% (39) 14.8% (4)
I ha e mode a e pain o discom o 49.4% (40) 77.8% (21)
I ha e a lo o pain o discom o 2.5% (2) 7.4% (2)
Anxie y/dep ession I am no anxious o dep essed 69.1% (56) 46.2% (12)
I am mode a ely anxious o dep essed 25.9% (21) 50.0% (13)
I am e y anxious o dep essed 4.9% (4) 3.8% (1)
Heal h s a us Be e 11.5% (6) 4.0% (1)
Same 30.8% (16) 8.0% (2)
Wo se 57.7% (30) 88.0% (22)
In pa en heses: numbe o pa ien s.
Table 7
Dis ibu ion o he di e en indica o s o heal h- ela ed quali y o li e based on cons i u ional symp om indica o s.
As henia
No Yes
Mobili y I ha e no p oblems walking 87.5% (14) 70.7% (65)
I ha e some p oblems walking 0.0% (0) 28.3% (26)
I ha e o s ay in bed 12.5% (2) 1.1% (1)
Pe sonal ca e I ha e no p oblems wi h pe sonal ca e 100.0% (13) 94.5% (86)
I ha e some p oblems washing mysel and ge ing d essed 0.0% (0) 5.5% (5)
I canno wash mysel o ge d essed 0.0% (0) 0.0% (0)
Daily ac i i ies I ha e no p oblems pe o ming my daily ac i i ies 81.3% (13) 47.8% (44)
I ha e some p oblems pe o ming my daily ac i i ies 18.8% (3) 51.1% (47)
I canno pe o m my daily ac i i ies 0.0% (0) 1.1% (1)
Pain/discom o I ha e no pain o discom o 68.8% (11) 34.8% (32)
I ha e mode a e pain o discom o 31.3% (5) 60.9% (56)
I ha e a lo o pain o discom o 0.0% (0) 4.3% (4)
Anxie y/dep ession I am no anxious o dep essed 75.0% (12) 61.5% (56)
I am mode a ely anxious o dep essed 25.0% (4) 33.0% (30)
I am e y anxious o dep essed 0.0% (0) 5.5% (5)
Heal h s a us Be e 0.0% (0) 10.1% (7)
Same 37.5% (3) 21.7% (15)
Wo se 62.5% (5) 68.1% (47)
In pa en heses: numbe o pa ien s.
P ie o-Calleje o e al. Medicine (2020) 99:33 Medicine
8
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023
indica o s. Focusing on each o he quali y-o -li e a iables, he e
a e di e ences in he in ol emen o ce ain oxici ies in he
di e en componen s.
On he one hand, he anxie y o dep ession indica o emains
a ec ed by nausea, mucosi is, pe iphe al neu opa hy, and
abdominal pain. As ega ds pain o discom o , 7 oxici ies
would be in ol ed: loss o appe i e, dysgeusia, pe iphe al
neu opa hy, a h algia, myalgia, as henia, and pe iphe al edema.
Daily ac i i ies a e influenced by loss o appe i e, pe iphe al
neu opa hy, and as henia. This las oxici y also has an impac on
he mobili y indica o , in addi ion o pe iphe al edema. Pe sonal
ca e is only a ec ed by pe iphe al neu opa hy.
In he case o pe iphe al neu opa hy and pe iphe al edema, i is
no ewo hy ha despi e ob aining a below 25% pe cen age o
p esence in he s udy pa ien s, hese a e oxici ies ha
significan ly a ec quali y o li e. This may be due o he lack
o alidi y o all he symp oms associa ed wi h hese a iables.
[6]
Pe iphe al neu opa hy is also wo h no ing because i is he
oxici y ha a ec s a g ea e numbe o quali y-o -li e indica o s
(anxie y o dep ession, pain o discom o , daily ac i i ies, and
pe sonal ca e). This may be due o he se e i y o his oxici y as i
a ec s he whole o ganism, om deep pain ollowed by
numbness, mainly in he hands and ee , muscle in ol emen
wi h a eeling o weakness, as well as p oblems wi h diges ing,
sexual ela ionships, hea in ol emen , and mo e.
Beus e ien e al
[18]
demons a ed in hei s udy ha b eas
cance pa ien s p io i ized ce ain side e ec s, such as pe iphe al
neu opa hy, o e o he s, such as alopecia, which hey conside ed
mino . They e en claimed o be willing o accep a less con enien
chemo he apy ea men scheme o a oid an inc eased isk o side
e ec s such as pe iphe al neu opa hy.
In sho , despi e he ad ances in he con ol o symp oms
associa ed wi h chemo he apy ea men s, he pa ien ’s pe cep-
ion is s ill a pending ask o all heal h wo ke s. These mus be
awa e o he impo ance o knowing he pa ien and hus
a oiding hospi al admissions, delays in chemo he apy cycles, o
e en suspension o he cycles as a esul o accumula ed
oxici y.
[11,14]
As o he limi a ions o his s udy, as a 1-cen e s udy, he e is a
possibili y ha he s udy popula ion will be subjec ed o ce ain
common bias. In addi ion, he ques ionnai e was ca ied ou
andomly in a specific cycle o he 6 co esponding o he
comple e ea men o he pa ien , so he e is a possibili y ha he
s udied cycle was no he one in which he pa ien p esen ed a
highe numbe o oxici ies. Simila ly, as an obse a ional design,
causal ela ionships canno be es ablished, and we can only alk
o co ela ions be ween he a iables. The e o e, u he s udies
wi h a la ge sample size would be needed o co obo a e he
esul s and conclusions o his s udy.
In gene al, quali y-o -li e esul s highligh he need o imp o e
he assessmen o he e ec s o he ea men on he pa ien s’
quali y o li e. This could be he goal o de eloping a sel - efillable
ques ionnai e ega ding he pa ien s’pe cep ion o hei own
heal h s a us and symp oms o ob ain mo e in o ma ion and
mo e de ailed da a on hese issues h ough pa ien sel -
assessmen . Pa ien s could b ing his sel -assessmen home o
ha e a digi al eco d a ailable wi h he aim o ob aining mo e
comple e da a on he ad e se eac ions su e ed du ing he 21
days he pa ien is a home. In his line, he e a e s udies
[9,34]
ha
ha e analyzed he pe cei ed quali y o li e o pa ien s as
compa ed wi h he usual p ac ice, which show ha quali y o
li e is a ec ed by he ca e ecei ed in hospi als du ing he pa ien ’s
illness, hus highligh ing he lack o in o ma ion ha heal h
p o essionals ha e abou pa ien s’pe cep ions.
The impo ance o in oducing a mul idisciplina y eam aimed
a imp o ing he accep ance o chemo he apy in hese pa ien s
has been demons a ed in a coho s udy conduc ed among
13,722 b eas cance pa ien s.
[36]
This is why his could be a line
o imp o emen in eal ca e o hese ypes o cance pa ien s.
On he o he hand, i would be necessa y o aise awa eness
among heal hca e p o essionals o he impo ance o ad e se
eac ions in chemo he apeu ic ea men s. Cance pa ien s may
eel mo e welcomed by he heal h sys em and mo e pa icipa i e
in e e y hing ha a ec s he e olu ion o hei ea men and
disease.
[11]
In conclusion, he p esence o ad e se eac ions ela ed o he
TEC ea men scheme significan ly dec eases heal h- ela ed
quali y o li e. In pa icula , nausea, loss o appe i e, dysgeusia,
pe iphe al neu opa hy, myalgia, and pe iphe al edema a e hose
oxici ies whe e his di e ence has been significan .
Au ho con ibu ions
Concep ualiza ion: Blanca P ie o-Calleje o.
Da a cu a ion: Blanca P ie o-Calleje o, F ancisco Ri e a.
Fo mal analysis: Blanca P ie o-Calleje o, F ancisco Ri e a,
Adol o Rome o, Maca ena Rome o-Ma ín.
In es iga ion: Blanca P ie o-Calleje o, Adol o Rome o, Ca los
Ruiz-F u os.
Me hodology: F ancisco Ri e a, Ja ie Fagundo-Ri e a, Adol o
Rome o, Maca ena Rome o-Ma ín, Juan Gómez-Salgado,
Ca los Ruiz-F u os.
P ojec adminis a ion: Blanca P ie o-Calleje o.
Resou ces: F ancisco Ri e a, Ja ie Fagundo-Ri e a, Juan
Gómez-Salgado, Ca los Ruiz-F u os.
So wa e: F ancisco Ri e a, Ja ie Fagundo-Ri e a.
Supe ision: Adol o Rome o, Juan Gómez-Salgado.
Valida ion: F ancisco Ri e a, Adol o Rome o.
Table 9
Co ela ion be ween ad e se eac ions and heal h- ela ed quali y
o li e.
Ad e se eac ion Mann–Whi ney U es PCohen d
Vomi ing 267 (77) .879 0.13
Nausea 440 (77) .020
∗
0.56
Dia hea 746 (78) .923 0.03
Cons ipa ion 613 (76) .522 0.17
Mucosi is 548 (77) .081 0.46
Loss o appe i e 455 (78) .002
∗
0.77
Dysgeusia 107 (78) .038
∗
0.89
Skin eac ion in
hands and/o ee
510 (77) .626 0.09
Impai ed nails 564 (77) .642 0.14
Skin alle gies 213 (76) .014 0.88
Pe iphe al neu opa hy 185 (77) .000
∗
1.34
Myalgia 628 (77) .248 0.30
Abdominal pain 559 (77) .104 0.37
Join pain 502 (77) .103 0.39
Muscle pain 436 (77) .003
∗
0.76
Conjunc i i is 581 (78) .148 0.35
As henia 168 (77) .068 0.64
Pe iphe al edema 337 (77) .001
∗
0.88
∗
S a is ically significan .
P ie o-Calleje o e al. Medicine (2020) 99:33 www.md-jou nal.com
9
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 05/16/2023